Conference

4th iPSC Drug Development & Manufacturing Summit

Oct 01 - 03, 2024

Boston, United States

The IPSC Therapies Summit is a leading conference dedicated to the advancement of induced pluripotent stem cell (iPSC) therapies. It brings together experts from academia, industry, and regulatory agencies to discuss the latest breakthroughs and challenges in the field. Attendees can expect a comprehensive program featuring keynote speeches, panel discussions, and networking opportunities, all focused on the potential of iPSC technology in regenerative medicine, drug discovery, and personalized therapies. The summit aims to foster collaboration and innovation among stakeholders to accelerate the translation of research into clinical applications.

In addition to scientific presentations, the summit emphasizes the importance of ethical considerations and regulatory frameworks surrounding iPSC research. It provides a platform for dialogue on best practices and the future direction of iPSC therapies. By showcasing case studies and successful applications, the conference highlights the transformative potential of iPSCs in treating various diseases. Participants leave with valuable insights and connections that can help advance their own work in this rapidly evolving field.

Stay ahead in the Pharma game

Register for this event now!

Speaker line up

Ali Turhan

Ali Turhan

iPSirius

CMO

Allen Feng

Allen Feng

HebeCell

Founder & Chief Scientific Officer

Anne Plant

Anne Plant

National Institute of Standards & Technology (NIST)

NIST Fellow

Annelise Bennaceur

Annelise Bennaceur

iPSirius

Chief Scientific Officer

Bar Makovoz

Bar Makovoz

Cellino Biotech Inc.

Principal Product Manager

Barbara Ressler

Barbara Ressler

Roslin Cell Therapies Ltd. (Roslin CT)

VP Process Sciences

Ben Duckless

Ben Duckless

Advanced Instruments, Inc.

Field Application Scientist

Bruna Paulsen

Bruna Paulsen

Gameto

Director - Manufacturing and Quality Control

Chong Luo

Chong Luo

Tome Biosciences

Director, Cell Therapy

Chris Barkey

Chris Barkey

Swissfinity Group

CEO

Daniel Terheyden-Keighley

Daniel Terheyden-Keighley

Catalent Pharma Solutions

Research & Development Scientist

Dhruv Sareen

Dhruv Sareen

Cedars-Sinai Medical Center

Associate Professor & Executive Director - Biomanufacturing Center & Induced Pluripotent Stem Cell

Dongsheng Guo

Dongsheng Guo

UMass Chan Medical School

Instructor

Fred CEDRONE

Fred CEDRONE

Catalent Pharma Solutions

Vice President - Corporate Innovation

George Barringer

George Barringer

Getinge

U.S. Manager - Cultivation Systems

Hannah Worden

Hannah Worden

PBS Biotech Inc.

Applications Engineer II

Harshyaa Makhija

Harshyaa Makhija

Nanyang Technological University

Dean's Postdoctoral Fellow

Howard Federoff

Howard Federoff

Kenai Therapeutics

Chief Medical Officer

Jes Kuruvilla

Jes Kuruvilla

MIFI Bioceuticals

Business Development Manager

Jesse Milling

Jesse Milling

bit.bio

Senior Director, Technical Operations

Joseph Wu

Joseph Wu

Stanford Cardiovascular Institute, Greenstone Biosciences

Professor

Kevin D’Amour

Kevin D’Amour

Stemson Therapeutics LLC

Chief Scientific Officer

Laura Koivusalo

Laura Koivusalo

StemSight

Chief Executive Officer

Leonardo Velazco-Cruz

Leonardo Velazco-Cruz

Thymmune Therapeutics

Senior Scientist

Matt Angel

Matt Angel

Factor Biosciences

Chief Executive Officer

Matt Moran

Matt Moran

Bayer

Senior Associate Development Engineer

Matthew Croughan

Matthew Croughan

PBS Biotech Inc.

Chief Technology Officer

Michael Naso

Michael Naso

Century Therapeutics

Vice President

Naqi Haider

Naqi Haider

Prime Medicine

Head of Stem Cell Biology

Nicholas Wisniewski

Nicholas Wisniewski

Stemson Therapeutics LLC

Vice President of Data Science and BioInformatics

Rajneesh Jha

Rajneesh Jha

AstraZeneca

Associate Principal Scientist

Sherry Hikita

Sherry Hikita

Novo Nordisk

Project Director

Sicco Popma

Sicco Popma

Accelerated Biosciences

Chief Scientific Officer

Toshinobu Nishimura

Toshinobu Nishimura

Century Therapeutics

Principal Scientist

Wei Li

Wei Li

Cytovia Therapeutics

Chief Scientific Officer

Will Ansari

Will Ansari

Aspen Neuroscience

Associate Director - Technology Development

Ali Turhan

Ali Turhan

iPSirius

CMO

Allen Feng

Allen Feng

HebeCell

Founder & Chief Scientific Officer

Anne Plant

Anne Plant

National Institute of Standards & Technology (NIST)

NIST Fellow

Annelise Bennaceur

Annelise Bennaceur

iPSirius

Chief Scientific Officer

Bar Makovoz

Bar Makovoz

Cellino Biotech Inc.

Principal Product Manager

Barbara Ressler

Barbara Ressler

Roslin Cell Therapies Ltd. (Roslin CT)

VP Process Sciences

Ben Duckless

Ben Duckless

Advanced Instruments, Inc.

Field Application Scientist

Bruna Paulsen

Bruna Paulsen

Gameto

Director - Manufacturing and Quality Control

Chong Luo

Chong Luo

Tome Biosciences

Director, Cell Therapy

Chris Barkey

Chris Barkey

Swissfinity Group

CEO

Daniel Terheyden-Keighley

Daniel Terheyden-Keighley

Catalent Pharma Solutions

Research & Development Scientist

Dhruv Sareen

Dhruv Sareen

Cedars-Sinai Medical Center

Associate Professor & Executive Director - Biomanufacturing Center & Induced Pluripotent Stem Cell

Dongsheng Guo

Dongsheng Guo

UMass Chan Medical School

Instructor

Fred CEDRONE

Fred CEDRONE

Catalent Pharma Solutions

Vice President - Corporate Innovation

George Barringer

George Barringer

Getinge

U.S. Manager - Cultivation Systems

Hannah Worden

Hannah Worden

PBS Biotech Inc.

Applications Engineer II

Harshyaa Makhija

Harshyaa Makhija

Nanyang Technological University

Dean's Postdoctoral Fellow

Howard Federoff

Howard Federoff

Kenai Therapeutics

Chief Medical Officer

Jes Kuruvilla

Jes Kuruvilla

MIFI Bioceuticals

Business Development Manager

Jesse Milling

Jesse Milling

bit.bio

Senior Director, Technical Operations

Joseph Wu

Joseph Wu

Stanford Cardiovascular Institute, Greenstone Biosciences

Professor

Kevin D’Amour

Kevin D’Amour

Stemson Therapeutics LLC

Chief Scientific Officer

Laura Koivusalo

Laura Koivusalo

StemSight

Chief Executive Officer

Leonardo Velazco-Cruz

Leonardo Velazco-Cruz

Thymmune Therapeutics

Senior Scientist

Matt Angel

Matt Angel

Factor Biosciences

Chief Executive Officer

Matt Moran

Matt Moran

Bayer

Senior Associate Development Engineer

Matthew Croughan

Matthew Croughan

PBS Biotech Inc.

Chief Technology Officer

Michael Naso

Michael Naso

Century Therapeutics

Vice President

Naqi Haider

Naqi Haider

Prime Medicine

Head of Stem Cell Biology

Nicholas Wisniewski

Nicholas Wisniewski

Stemson Therapeutics LLC

Vice President of Data Science and BioInformatics

Rajneesh Jha

Rajneesh Jha

AstraZeneca

Associate Principal Scientist

Sherry Hikita

Sherry Hikita

Novo Nordisk

Project Director

Sicco Popma

Sicco Popma

Accelerated Biosciences

Chief Scientific Officer

Toshinobu Nishimura

Toshinobu Nishimura

Century Therapeutics

Principal Scientist

Wei Li

Wei Li

Cytovia Therapeutics

Chief Scientific Officer

Will Ansari

Will Ansari

Aspen Neuroscience

Associate Director - Technology Development

Ali Turhan

Ali Turhan

iPSirius

CMO

Allen Feng

Allen Feng

HebeCell

Founder & Chief Scientific Officer

Anne Plant

Anne Plant

National Institute of Standards & Technology (NIST)

NIST Fellow

Annelise Bennaceur

Annelise Bennaceur

iPSirius

Chief Scientific Officer

Bar Makovoz

Bar Makovoz

Cellino Biotech Inc.

Principal Product Manager

Barbara Ressler

Barbara Ressler

Roslin Cell Therapies Ltd. (Roslin CT)

VP Process Sciences

Ben Duckless

Ben Duckless

Advanced Instruments, Inc.

Field Application Scientist

Bruna Paulsen

Bruna Paulsen

Gameto

Director - Manufacturing and Quality Control

Chong Luo

Chong Luo

Tome Biosciences

Director, Cell Therapy

Chris Barkey

Chris Barkey

Swissfinity Group

CEO

Daniel Terheyden-Keighley

Daniel Terheyden-Keighley

Catalent Pharma Solutions

Research & Development Scientist

Dhruv Sareen

Dhruv Sareen

Cedars-Sinai Medical Center

Associate Professor & Executive Director - Biomanufacturing Center & Induced Pluripotent Stem Cell

Dongsheng Guo

Dongsheng Guo

UMass Chan Medical School

Instructor

Fred CEDRONE

Fred CEDRONE

Catalent Pharma Solutions

Vice President - Corporate Innovation

George Barringer

George Barringer

Getinge

U.S. Manager - Cultivation Systems

Hannah Worden

Hannah Worden

PBS Biotech Inc.

Applications Engineer II

Harshyaa Makhija

Harshyaa Makhija

Nanyang Technological University

Dean's Postdoctoral Fellow

Howard Federoff

Howard Federoff

Kenai Therapeutics

Chief Medical Officer

Jes Kuruvilla

Jes Kuruvilla

MIFI Bioceuticals

Business Development Manager

Jesse Milling

Jesse Milling

bit.bio

Senior Director, Technical Operations

Joseph Wu

Joseph Wu

Stanford Cardiovascular Institute, Greenstone Biosciences

Professor

Kevin D’Amour

Kevin D’Amour

Stemson Therapeutics LLC

Chief Scientific Officer

Laura Koivusalo

Laura Koivusalo

StemSight

Chief Executive Officer

Leonardo Velazco-Cruz

Leonardo Velazco-Cruz

Thymmune Therapeutics

Senior Scientist

Matt Angel

Matt Angel

Factor Biosciences

Chief Executive Officer

Matt Moran

Matt Moran

Bayer

Senior Associate Development Engineer

Matthew Croughan

Matthew Croughan

PBS Biotech Inc.

Chief Technology Officer

Michael Naso

Michael Naso

Century Therapeutics

Vice President

Naqi Haider

Naqi Haider

Prime Medicine

Head of Stem Cell Biology

Nicholas Wisniewski

Nicholas Wisniewski

Stemson Therapeutics LLC

Vice President of Data Science and BioInformatics

Rajneesh Jha

Rajneesh Jha

AstraZeneca

Associate Principal Scientist

Sherry Hikita

Sherry Hikita

Novo Nordisk

Project Director

Sicco Popma

Sicco Popma

Accelerated Biosciences

Chief Scientific Officer

Toshinobu Nishimura

Toshinobu Nishimura

Century Therapeutics

Principal Scientist

Wei Li

Wei Li

Cytovia Therapeutics

Chief Scientific Officer

Will Ansari

Will Ansari

Aspen Neuroscience

Associate Director - Technology Development

About the Organiser

A Hanson Wade Group Company

Hanson Wade Group 52 Grosvenor Gardens, London, United Kingdom

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

Frequently Asked Questions
What is the focus of the summit?
The summit combines iPSC-Derived Cell Therapies and iPSC Manufacturing, focusing on R&D, manufacturing, and analytical development.
Who should attend this summit?
Drug developers, academic leaders, and professionals in iPSC cell therapies.
What topics will be covered?
Gene editing, scalable manufacturing, and AI in autonomous processes.
When and where is the event?
Yes, with dedicated networking sessions and poster presentations.

Day and Timing

Tuesday, Oct 1 - 3 · 09:00 AM - 18:00 PM

Location

Boston, United States

Entry Fees

Paid

Frequency

Annual

Event Type

Conference

Duration

October 1-3, 2024

Website

ipsc-therapies-summit.com
Ad
Advertisement
News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news

Stay ahead in the Pharma game

Register for this event now!

Day and Timing

Tuesday, Oct 1 - 3 · 09:00 AM - 18:00 PM

Location

Boston, United States

Entry Fees

Paid

Frequency

Annual

Event Type

Conference

Duration

October 1-3, 2024

Website

ipsc-therapies-summit.com

Speaker line up

Ali Turhan

Ali Turhan

iPSirius

CMO

Allen Feng

Allen Feng

HebeCell

Founder & Chief Scientific Officer

Anne Plant

Anne Plant

National Institute of Standards & Technology (NIST)

NIST Fellow

Annelise Bennaceur

Annelise Bennaceur

iPSirius

Chief Scientific Officer

Bar Makovoz

Bar Makovoz

Cellino Biotech Inc.

Principal Product Manager

Barbara Ressler

Barbara Ressler

Roslin Cell Therapies Ltd. (Roslin CT)

VP Process Sciences

Ben Duckless

Ben Duckless

Advanced Instruments, Inc.

Field Application Scientist

Bruna Paulsen

Bruna Paulsen

Gameto

Director - Manufacturing and Quality Control

Chong Luo

Chong Luo

Tome Biosciences

Director, Cell Therapy

Chris Barkey

Chris Barkey

Swissfinity Group

CEO

Daniel Terheyden-Keighley

Daniel Terheyden-Keighley

Catalent Pharma Solutions

Research & Development Scientist

Dhruv Sareen

Dhruv Sareen

Cedars-Sinai Medical Center

Associate Professor & Executive Director - Biomanufacturing Center & Induced Pluripotent Stem Cell

Dongsheng Guo

Dongsheng Guo

UMass Chan Medical School

Instructor

Fred CEDRONE

Fred CEDRONE

Catalent Pharma Solutions

Vice President - Corporate Innovation

George Barringer

George Barringer

Getinge

U.S. Manager - Cultivation Systems

Hannah Worden

Hannah Worden

PBS Biotech Inc.

Applications Engineer II

Harshyaa Makhija

Harshyaa Makhija

Nanyang Technological University

Dean's Postdoctoral Fellow

Howard Federoff

Howard Federoff

Kenai Therapeutics

Chief Medical Officer

Jes Kuruvilla

Jes Kuruvilla

MIFI Bioceuticals

Business Development Manager

Jesse Milling

Jesse Milling

bit.bio

Senior Director, Technical Operations

Joseph Wu

Joseph Wu

Stanford Cardiovascular Institute, Greenstone Biosciences

Professor

Kevin D’Amour

Kevin D’Amour

Stemson Therapeutics LLC

Chief Scientific Officer

Laura Koivusalo

Laura Koivusalo

StemSight

Chief Executive Officer

Leonardo Velazco-Cruz

Leonardo Velazco-Cruz

Thymmune Therapeutics

Senior Scientist

Matt Angel

Matt Angel

Factor Biosciences

Chief Executive Officer

Matt Moran

Matt Moran

Bayer

Senior Associate Development Engineer

Matthew Croughan

Matthew Croughan

PBS Biotech Inc.

Chief Technology Officer

Michael Naso

Michael Naso

Century Therapeutics

Vice President

Naqi Haider

Naqi Haider

Prime Medicine

Head of Stem Cell Biology

Nicholas Wisniewski

Nicholas Wisniewski

Stemson Therapeutics LLC

Vice President of Data Science and BioInformatics

Rajneesh Jha

Rajneesh Jha

AstraZeneca

Associate Principal Scientist

Sherry Hikita

Sherry Hikita

Novo Nordisk

Project Director

Sicco Popma

Sicco Popma

Accelerated Biosciences

Chief Scientific Officer

Toshinobu Nishimura

Toshinobu Nishimura

Century Therapeutics

Principal Scientist

Wei Li

Wei Li

Cytovia Therapeutics

Chief Scientific Officer

Will Ansari

Will Ansari

Aspen Neuroscience

Associate Director - Technology Development

Ali Turhan

Ali Turhan

iPSirius

CMO

Allen Feng

Allen Feng

HebeCell

Founder & Chief Scientific Officer

Anne Plant

Anne Plant

National Institute of Standards & Technology (NIST)

NIST Fellow

Annelise Bennaceur

Annelise Bennaceur

iPSirius

Chief Scientific Officer

Bar Makovoz

Bar Makovoz

Cellino Biotech Inc.

Principal Product Manager

Barbara Ressler

Barbara Ressler

Roslin Cell Therapies Ltd. (Roslin CT)

VP Process Sciences

Ben Duckless

Ben Duckless

Advanced Instruments, Inc.

Field Application Scientist

Bruna Paulsen

Bruna Paulsen

Gameto

Director - Manufacturing and Quality Control

Chong Luo

Chong Luo

Tome Biosciences

Director, Cell Therapy

Chris Barkey

Chris Barkey

Swissfinity Group

CEO

Daniel Terheyden-Keighley

Daniel Terheyden-Keighley

Catalent Pharma Solutions

Research & Development Scientist

Dhruv Sareen

Dhruv Sareen

Cedars-Sinai Medical Center

Associate Professor & Executive Director - Biomanufacturing Center & Induced Pluripotent Stem Cell

Dongsheng Guo

Dongsheng Guo

UMass Chan Medical School

Instructor

Fred CEDRONE

Fred CEDRONE

Catalent Pharma Solutions

Vice President - Corporate Innovation

George Barringer

George Barringer

Getinge

U.S. Manager - Cultivation Systems

Hannah Worden

Hannah Worden

PBS Biotech Inc.

Applications Engineer II

Harshyaa Makhija

Harshyaa Makhija

Nanyang Technological University

Dean's Postdoctoral Fellow

Howard Federoff

Howard Federoff

Kenai Therapeutics

Chief Medical Officer

Jes Kuruvilla

Jes Kuruvilla

MIFI Bioceuticals

Business Development Manager

Jesse Milling

Jesse Milling

bit.bio

Senior Director, Technical Operations

Joseph Wu

Joseph Wu

Stanford Cardiovascular Institute, Greenstone Biosciences

Professor

Kevin D’Amour

Kevin D’Amour

Stemson Therapeutics LLC

Chief Scientific Officer

Laura Koivusalo

Laura Koivusalo

StemSight

Chief Executive Officer

Leonardo Velazco-Cruz

Leonardo Velazco-Cruz

Thymmune Therapeutics

Senior Scientist

Matt Angel

Matt Angel

Factor Biosciences

Chief Executive Officer

Matt Moran

Matt Moran

Bayer

Senior Associate Development Engineer

Matthew Croughan

Matthew Croughan

PBS Biotech Inc.

Chief Technology Officer

Michael Naso

Michael Naso

Century Therapeutics

Vice President

Naqi Haider

Naqi Haider

Prime Medicine

Head of Stem Cell Biology

Nicholas Wisniewski

Nicholas Wisniewski

Stemson Therapeutics LLC

Vice President of Data Science and BioInformatics

Rajneesh Jha

Rajneesh Jha

AstraZeneca

Associate Principal Scientist

Sherry Hikita

Sherry Hikita

Novo Nordisk

Project Director

Sicco Popma

Sicco Popma

Accelerated Biosciences

Chief Scientific Officer

Toshinobu Nishimura

Toshinobu Nishimura

Century Therapeutics

Principal Scientist

Wei Li

Wei Li

Cytovia Therapeutics

Chief Scientific Officer

Will Ansari

Will Ansari

Aspen Neuroscience

Associate Director - Technology Development

Ali Turhan

Ali Turhan

iPSirius

CMO

Allen Feng

Allen Feng

HebeCell

Founder & Chief Scientific Officer

Anne Plant

Anne Plant

National Institute of Standards & Technology (NIST)

NIST Fellow

Annelise Bennaceur

Annelise Bennaceur

iPSirius

Chief Scientific Officer

Bar Makovoz

Bar Makovoz

Cellino Biotech Inc.

Principal Product Manager

Barbara Ressler

Barbara Ressler

Roslin Cell Therapies Ltd. (Roslin CT)

VP Process Sciences

Ben Duckless

Ben Duckless

Advanced Instruments, Inc.

Field Application Scientist

Bruna Paulsen

Bruna Paulsen

Gameto

Director - Manufacturing and Quality Control

Chong Luo

Chong Luo

Tome Biosciences

Director, Cell Therapy

Chris Barkey

Chris Barkey

Swissfinity Group

CEO

Daniel Terheyden-Keighley

Daniel Terheyden-Keighley

Catalent Pharma Solutions

Research & Development Scientist

Dhruv Sareen

Dhruv Sareen

Cedars-Sinai Medical Center

Associate Professor & Executive Director - Biomanufacturing Center & Induced Pluripotent Stem Cell

Dongsheng Guo

Dongsheng Guo

UMass Chan Medical School

Instructor

Fred CEDRONE

Fred CEDRONE

Catalent Pharma Solutions

Vice President - Corporate Innovation

George Barringer

George Barringer

Getinge

U.S. Manager - Cultivation Systems

Hannah Worden

Hannah Worden

PBS Biotech Inc.

Applications Engineer II

Harshyaa Makhija

Harshyaa Makhija

Nanyang Technological University

Dean's Postdoctoral Fellow

Howard Federoff

Howard Federoff

Kenai Therapeutics

Chief Medical Officer

Jes Kuruvilla

Jes Kuruvilla

MIFI Bioceuticals

Business Development Manager

Jesse Milling

Jesse Milling

bit.bio

Senior Director, Technical Operations

Joseph Wu

Joseph Wu

Stanford Cardiovascular Institute, Greenstone Biosciences

Professor

Kevin D’Amour

Kevin D’Amour

Stemson Therapeutics LLC

Chief Scientific Officer

Laura Koivusalo

Laura Koivusalo

StemSight

Chief Executive Officer

Leonardo Velazco-Cruz

Leonardo Velazco-Cruz

Thymmune Therapeutics

Senior Scientist

Matt Angel

Matt Angel

Factor Biosciences

Chief Executive Officer

Matt Moran

Matt Moran

Bayer

Senior Associate Development Engineer

Matthew Croughan

Matthew Croughan

PBS Biotech Inc.

Chief Technology Officer

Michael Naso

Michael Naso

Century Therapeutics

Vice President

Naqi Haider

Naqi Haider

Prime Medicine

Head of Stem Cell Biology

Nicholas Wisniewski

Nicholas Wisniewski

Stemson Therapeutics LLC

Vice President of Data Science and BioInformatics

Rajneesh Jha

Rajneesh Jha

AstraZeneca

Associate Principal Scientist

Sherry Hikita

Sherry Hikita

Novo Nordisk

Project Director

Sicco Popma

Sicco Popma

Accelerated Biosciences

Chief Scientific Officer

Toshinobu Nishimura

Toshinobu Nishimura

Century Therapeutics

Principal Scientist

Wei Li

Wei Li

Cytovia Therapeutics

Chief Scientific Officer

Will Ansari

Will Ansari

Aspen Neuroscience

Associate Director - Technology Development

About the Organiser

A Hanson Wade Group Company

Hanson Wade Group 52 Grosvenor Gardens, London, United Kingdom

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

Ad
Advertisement
Frequently Asked Questions
What is the focus of the summit?
The summit combines iPSC-Derived Cell Therapies and iPSC Manufacturing, focusing on R&D, manufacturing, and analytical development.
Who should attend this summit?
Drug developers, academic leaders, and professionals in iPSC cell therapies.
What topics will be covered?
Gene editing, scalable manufacturing, and AI in autonomous processes.
When and where is the event?
Yes, with dedicated networking sessions and poster presentations.

More Events

Conference

6th Annual Pharma Manufacturing and Automation Convention 2024

Oct 17 - 18, 2024

Hyderabad, India

Conference

19th International Conference of Drug Regulatory Authorities

Oct 14 - 18, 2024

New Delhi, India

Conference

The Pharma Industry CEO Conclave

Oct 19 - 19, 2024

Pune, India

View All

News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news